The brokerage has a ‘buy’ recommendation on the stock with a target price of ₹528, indicating an upside of 10 percent from its current market price of ₹480.30.
Aarti Drugs share price: On technical setup, the stock was last seen trading higher than the 5-day, 20-, 50-, 100- and 200-day moving averages. The counter's 14-day relative strength index (RSI) came at 83.71. A level below 30 is defined as oversold while a value above 70 is considered overbought. The company's stock has a price-to-earnings (P/E) ratio of 28.48 against a price-to-book (P/B) value of 4.24.
Aarti Drugs Wins Pharmexcil Outstanding Exports Award 2021-2022 freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.
Get latest articles and stories on Business at LatestLY. Mumbai (Maharashtra)/ Ahmedabad (Gujarat)/ Prozeal Infra Engineering Pvt. Ltd. has announced their first round of funding led by Chandrakant Gogri s family office arm - Alchemie Ventures. The USD 4 Million (approx. INR 32.5 Crore) investment is for a minority stake at an undisclosed valuation. The funds will be used to scale operations and execute developer-model projects for energy and utility companies. Incorp Advisory was the exclusive investment banker for the transaction, which represents the largest Series-A fundraising transaction in India s Solar EPC space in over 2 years. Business News | Chandrakant Gogri s Family Office Leads a USD 4 Million Series A Investment in Prozeal Infra.